RecruitingNot Applicable

Pseudophakic Eyes With Presbyopia-correcting IOLs: OCT Biometry and Pyramid Aberrometry

Austria80 participantsStarted 2024-04-04

Plain-language summary

To correlate ocular morphology from anterior segment OCT and pyramid wavefront sensing in order to comprehensively analyze pseudophakic in vivo image quality of presbyopia-correcting IOLs in cataract patients.

Who can participate

Age range21 Years – 110 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Men and women aged above 21 years with prior uncomplicated cataract/IOL exchange surgery
✓. Willing to sign informed consent before measurements
✓. Corrected distance visual acuity (CDVA) of 0.1 logMAR or better
✓. Absence of corneal scars/dry eye disease that could falsify the light transmission of the study eye
✓. Total absence of posterior capsule opacification or patients who already have undergone Nd:YAG capsulotomy
✓. Absence of ocular comorbidity (Macular degeneration, glaucoma, amblyopia)

Exclusion criteria

✕. Prior corneal refractive or ocular surgery
✕. Posterior capsule opacification.
✕. Keratometry between \<42.5 and \>45 D,
✕. Corneal spherical aberration \> 0.4 microns 5) Angle kappa \> 0.4 mm

What they're measuring

IOL ocular optics measument

Timeframe: 24 months

Trial details

NCT IDNCT07436247

SponsorPrim. Prof. Dr. Oliver Findl, MBA

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-04-01

Contact for this trial

Stefan Georgiev, MD, PhD

+43 1 91021 office@viros.at

View on ClinicalTrials.gov More Cataract trials